CNSL — Cambridge Nutritional Sciences Balance Sheet
0.000.00%
Last trade - 00:00- £4.16m
- £1.65m
- £6.98m
Annual balance sheet for Cambridge Nutritional Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.6 | 5.12 | 5.44 | 4.87 | 2.64 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.84 | 2.33 | 1.7 | 1.77 | 1.95 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 5.74 | 8.29 | 7.88 | 7.66 | 5.65 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.24 | 0.588 | 0.514 | 0.761 | 0.813 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 17.8 | 14.4 | 13.9 | 13.7 | 7.37 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 2.97 | 1.58 | 1.45 | 2.12 | 1.66 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.02 | 4.45 | 4.21 | 2.24 | 1.69 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11.8 | 9.95 | 9.68 | 11.4 | 5.68 |
| Total Liabilities & Shareholders' Equity | 17.8 | 14.4 | 13.9 | 13.7 | 7.37 |
| Total Common Shares Outstanding |